Journal of Pain and Palliative Care Pharmacotherapy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Mpox Pain Management and Topical Agents
J Pain Palliat Care Pharmacother. 2023 Dec;37(4):270-271. doi: 10.1080/15360288.2023.2276930. Epub 2023 Nov 28.NO ABSTRACTPMID:38015203 | DOI:10.1080/15360288.2023.2276930 (Source: Journal of Pain and Palliative Care Pharmacotherapy)
Source: Journal of Pain and Palliative Care Pharmacotherapy - November 28, 2023 Category: Palliative Care Authors: Hinpetch Daungsupawong Viroj Wiwanitkit Source Type: research

The Use of Ketamine for Malignant and Nonmalignant Chronic Pain in Children: A Review of Current Evidence
This article aims to provide an overview of its properties and highlight the current evidence for its use in malignant and nonmalignant chronic pain management. A search on the use of ketamine for chronic pain in children up to 18 years of age covering the period from January 1, 2000, to December 14, 2022, was performed through PubMed, Cochrane Library, EBSCO, EBM Review, Wiley, BMJ, Web of Science, Google Scholar, and the Saudi Digital Library. 218 articles were found and 42 underwent full review. Currently, the evidence about ketamine efficacity and safety for chronic pain management is at best of moderate to low quality...
Source: Journal of Pain and Palliative Care Pharmacotherapy - November 27, 2023 Category: Palliative Care Authors: Khaled AlGhamdi Kim Sadler Source Type: research

Use of Fosaprepitant for Management of Suspected Antimicrobial-Associated Nausea: A Case Report
We report on a 49-year-old woman with a past medical history of cystic fibrosis (CF) with chronic hypoxia, chronic nausea, complex infection history and frequent hospitalizations who was admitted to an academic medical center with a CF exacerbation. Her chronic nausea worsened with the use of antimicrobials, and she was unable to tolerate dopamine or serotonin antagonist antiemetics. Nausea persisted despite the use of benzodiazepines and antihistamines. She was given a one-time dose of fosaprepitant 150 mg intravenously (IV) with marked improvement of her nausea. During subsequent exacerbations, she again developed severe...
Source: Journal of Pain and Palliative Care Pharmacotherapy - November 20, 2023 Category: Palliative Care Authors: Brandon Perkovich Rabia S Atayee Jennifer S Kim Tamara Rubenzik Source Type: research

Peer Review Questions & amp; Answers: How? Part III: Writing the Reviewer Report
J Pain Palliat Care Pharmacother. 2023 Oct 25:1-3. doi: 10.1080/15360288.2023.2271817. Online ahead of print.NO ABSTRACTPMID:37878261 | DOI:10.1080/15360288.2023.2271817 (Source: Journal of Pain and Palliative Care Pharmacotherapy)
Source: Journal of Pain and Palliative Care Pharmacotherapy - October 25, 2023 Category: Palliative Care Authors: Laura Meyer-Junco Source Type: research